A Pre-market, Two-stages Interventional Clinical Investigation to Evaluate the Safety and the Performance of Fibroin Syrup in Reducing the Gastroesophageal Reflux Disease (GERD) Symptomatology in Nonerosive Reflux Disease (NERD) Patients

Clinical trial NCT07563790 · COMPLETED

Trial details

NCT number: NCT07563790
Sponsor: Rose Pharma SA
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

GERD (Heartburn, Regurgitation, and Dyspepsia)Gastroesophageal Reflux (GERD)

Start date: 2024-07-24
Primary completion: 2025-07-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.